These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2890366)

  • 21. The effect of phenytoin on the magnitude and duration of neuromuscular block following atracurium or vecuronium.
    Ornstein E; Matteo RS; Schwartz AE; Silverberg PA; Young WL; Diaz J
    Anesthesiology; 1987 Aug; 67(2):191-6. PubMed ID: 2886081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-response relation for atracurium, ORG NC 45 and pancuronium.
    Gramstad L; Lilleaasen P
    Br J Anaesth; 1982 Jun; 54(6):647-51. PubMed ID: 6123339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pharmacokinetic explanation for increasing recovery time following larger or repeated doses of nondepolarizing muscle relaxants.
    Fisher DM; Rosen JI
    Anesthesiology; 1986 Sep; 65(3):286-91. PubMed ID: 2875680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Some effects of diisopropyl phenol (ICI 35 868) on the pharmacodynamics of atracurium and vecuronium in anaesthetized man.
    Robertson EN; Fragen RJ; Booij LH; van Egmond J; Crul JF
    Br J Anaesth; 1983 Aug; 55(8):723-8. PubMed ID: 6136286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of isoflurane and sevoflurane on the magnitude and time course of neuromuscular block produced by vecuronium, pancuronium and atracurium.
    Vanlinthout LE; Booij LH; van Egmond J; Robertson EN
    Br J Anaesth; 1996 Mar; 76(3):389-95. PubMed ID: 8785139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between nondepolarizing neuromuscular blocking agents and inhalational anesthetics.
    Swen J; Rashkovsky OM; Ket JM; Koot HW; Hermans J; Agoston S
    Anesth Analg; 1989 Dec; 69(6):752-5. PubMed ID: 2574015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of large dose of vecuronium with pancuronium for prolonged neuromuscular blockade.
    Rørvik K; Husby P; Gramstad L; Vamnes JS; Bitsch-Larsen L; Koller ME
    Br J Anaesth; 1988 Aug; 61(2):180-5. PubMed ID: 2901270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-response relation, neuromuscular blocking action, intubation conditions, and cardiovascular effects of Org 9273, a new neuromuscular blocking agent.
    van den Broek L; Lambalk LM; Richardson FJ; Wierda JM
    Anesth Analg; 1991 Jun; 72(6):811-6. PubMed ID: 1674648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The dose-response relationship and time course of the neuromuscular blockade by alcuronium].
    Pühringer F; Adler R; Mitterschiffthaler G; Koller J; Mair P; Khünl-Brady KS; Agoston S
    Anaesthesist; 1990 Oct; 39(10):508-12. PubMed ID: 1980578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potency and maintenance requirement of atracurium and vecuronium given alone or together.
    Rautoma P; Erkola O; Meretoja OA
    Acta Anaesthesiol Scand; 1995 Feb; 39(2):220-3. PubMed ID: 7793191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacodynamics of vecuronium, atracurium, tubocurarine and their combinations in the rat in vivo.
    Booij LH; van Egmond J; van de Pol F; Crul JF
    Eur J Anaesthesiol; 1985 Sep; 2(3):279-84. PubMed ID: 2866094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypothermic cardiopulmonary bypass and neuromuscular blockade by pancuronium and vecuronium.
    Buzello W; Schluermann D; Schindler M; Spillner G
    Anesthesiology; 1985 Feb; 62(2):201-4. PubMed ID: 2857541
    [No Abstract]   [Full Text] [Related]  

  • 33. Interaction between pancuronium bromide and vecuronium bromide.
    Rashkovsky OM; Agoston S; Ket JM
    Br J Anaesth; 1985 Nov; 57(11):1063-6. PubMed ID: 2864945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuromuscular and vagal blocking actions of pancuronium bromide, its metabolites, and vecuronium bromide (Org NC45) and its potential metabolites in the anaesthetized cat.
    Marshall IG; Gibb AJ; Durant NN
    Br J Anaesth; 1983 Aug; 55(8):703-14. PubMed ID: 6136285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative potency of steroidal neuromuscular blocking drugs and isobolographic analysis of the interaction between rocuronium and other aminosteroids.
    Naguib M; Samarkandi AH; Bakhamees HS; Magboul MA; el-Bakry AK
    Br J Anaesth; 1995 Jul; 75(1):37-42. PubMed ID: 7669466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo potentiation of atracurium neuromuscular blockade by nimodipine in rabbits.
    Gómez-Iglesias E; García E; Suarez E; Martínez R; Rodríguez-Sasiaín JM; Calvo R
    Acta Anaesthesiol Scand; 1992 Jan; 36(1):67-9. PubMed ID: 1311493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atracurium and vecuronium: repeated bolus injection versus infusion.
    Diefenbach C; Mellinghoff H; Grond S; Buzello W
    Anesth Analg; 1992 Apr; 74(4):519-22. PubMed ID: 1348167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of volatile anesthetics on vecuronium-induced neuromuscular blockade in children.
    Pittet JF; Melis A; Rouge JC; Morel DR; Gemperle G; Tassonyi E
    Anesth Analg; 1990 Mar; 70(3):248-52. PubMed ID: 1968320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuromuscular blocking and autonomic effects of vecuronium and atracurium in the anaesthetized cat.
    Sutherland GA; Squire IB; Gibb AJ; Marshall IG
    Br J Anaesth; 1983 Nov; 55(11):1119-26. PubMed ID: 6139121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recovery of neuromuscular function after infusion or intermittent bolus doses of atracurium or vecuronium.
    Gordon KL; Reilly CS
    Br J Anaesth; 1989 Mar; 62(3):269-73. PubMed ID: 2564782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.